C355-1352 Screening compound: ethyl 3-(5-{[(6Z)-5-imino-7-oxo-3-(propane-2-sulfonyl)-5H,6H,7H-[1,2,4]thiadiazolo[4,5-a]pyrimidin-6-ylidene]methyl}furan-2-yl)benzoate

C355-1352 Screening compound: ethyl 3-(5-{[(6Z)-5-imino-7-oxo-3-(propane-2-sulfonyl)-5H,6H,7H-[1,2,4]thiadiazolo[4,5-a]pyrimidin-6-ylidene]methyl}furan-2-yl)benzoate
C355-1352 Screening compound: ethyl 3-(5-{[(6Z)-5-imino-7-oxo-3-(propane-2-sulfonyl)-5H,6H,7H-[1,2,4]thiadiazolo[4,5-a]pyrimidin-6-ylidene]methyl}furan-2-yl)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound C355-1352
ethyl 3-(5-{[(6Z)-5-imino-7-oxo-3-(propane-2-sulfonyl)-5H,6H,7H-[1,2,4]thiadiazolo[4,5-a]pyrimidin-6-ylidene]methyl}furan-2-yl)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C355-1352

Molecular Formula

C22H20N4O6S2 (C22 H20 N4 O6 S2)

Compound Name

ethyl 3-(5-{[(6Z)-5-imino-7-oxo-3-(propane-2-sulfonyl)-5H,6H,7H-[1,2,4]thiadiazolo[4,5-a]pyrimidin-6-ylidene]methyl}furan-2-yl)benzoate

IUPAC name

ethyl 3-(5-{[(6Z)-5-imino-7-oxo-3-(propane-2-sulfonyl)-5H6H7H-[124]thiadiazolo[45-a]pyrimidin-6-ylidene]methyl}furan-2-yl)benzoate

SMILES

CCOC(c1cccc(-c2ccc(/C=C(/C(N(C(S(C(C)C)(=O)=O)=NS3)C3=N3)=N)\C3=O)o2)c1)=O

InChI

InChI=1S/C22H20N4O6S2/c1-4-31-20(28)14-7-5-6-13(10-14)17-9-8-15(32-17)11-16-18(23)26-21(24-19(16)27)33-25-22(26)34(29,30)12(2)3/h5-12,23H,4H2,1-3H3

InChI Key

PCBRFGKEQFMOLQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14751761

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

500.56

Hydrogen Bond Acceptors Count

14.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.286

Distribution Coefficient, logD

3.285

Water Solubility, LogSw

-3.57

Polar Surface Area

109.366

Acid Dissociation Constant (pKa)

19.65

Base Dissociation Constant (pKb)

4.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

C355-1352 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C355-1352 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C355-1352?
Check Price and Availability of C355-1352, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C355-1352 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C355-1352
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C355-1352
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C355-1352 available by request